Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Watson gets rights to Itero's rFSH for female infertility

Executive Summary

Watson Pharmaceuticals Inc. (generics and branded urology and women's health products) has received exclusive worldwide rights to Itero Biopharmaceuticals Inc.'s (protein therapeutics) recombinant follicle-stimulating hormone (rFSH), which is in preclinical studies for female infertility.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)

Related Companies